Tuberculosis and Respiratory Diseases

eISSN: 2005-6184pISSN: 1738-3536
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
5.1
H-Index
31
SJR
Q2Infectious Diseases
SNIP
1.08

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    TAEHAN KYORHAEK HYOPHOE-KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES
  • Language
    English
  • Frequency
    Quarterly
  • Publication Time
    12
  • Editorial Review Process
    Anonymous peer review
General Details
  • Language
    English
  • Society/Institute/Sponsor
    The Korean Academy of Tuberculosis and Respiratory Diseases
  • Frequency
    Quarterly
  • Publication Start Year
    1954
  • Publisher URL
  • Website URL
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Lung
Bronchoscopy
Murine model
Lung cancer
Dexamethasone
Asthma
COPD
Intensive care
Mechanical ventilation
Pneumonia
Exercise
Thoracic radiotherapy
Pulmonary rehabilitation
Gene expression
Inhalation
Pulmonary embolism
Esophageal cancer
Smoking cessation
Respiratory disease
Diagnostic accuracy

Recently Published Papers

Year-wise Publication

FAQs

Since when has Tuberculosis and Respiratory Diseases been publishing? Faqs

The Tuberculosis and Respiratory Diseases has been publishing since 1954 till date.

How frequently is the Tuberculosis and Respiratory Diseases published? Faqs

Tuberculosis and Respiratory Diseases is published Quarterly.

What is the H-index. SNIP score, Citescore and SJR of Tuberculosis and Respiratory Diseases? Faqs

Tuberculosis and Respiratory Diseases has a H-index score of 31, Citescore of 5.1, SNIP score of 1.08, & SJR of Q2

Who is the publisher of Tuberculosis and Respiratory Diseases? Faqs

The publisher of Tuberculosis and Respiratory Diseases is TAEHAN KYORHAEK HYOPHOE-KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES.

How can I view the journal metrics of Tuberculosis and Respiratory Diseases on editage? Faqs

For the Tuberculosis and Respiratory Diseases metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Tuberculosis and Respiratory Diseases? Faqs

The eISSN number is 2005-6184 and pISSN number is 1738-3536 for Tuberculosis and Respiratory Diseases.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Lung, Bronchoscopy, Murine model, Lung cancer, Dexamethasone, Asthma, COPD, Intensive care, Mechanical ventilation, Pneumonia, Exercise, Thoracic radiotherapy, Pulmonary rehabilitation, Gene expression, Inhalation, Pulmonary embolism, Esophageal cancer, Smoking cessation, Respiratory disease, Diagnostic accuracy.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.